CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

CONMED Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$46.05−0.67 (-1.43%)

Close on Oct 19, 2026

Market cap: $1.39B
P/E (TTM): 24.9
Dividend yield: 1.30%

CONMED Corp income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	1,375	1,307	1,245	1,045	1,011	862	955	860	796	764	719	740	763	767	725	714	695
Cost of Revenue	624	574	568	474	443	402	430	391	365	355	337	336	350	361	350	348	357
Gross Profit	750	733	676	571	568	460	525	469	431	408	382	404	412	406	375	365	337
Research & Development	56	54	53	47	44	40	45	42	32	32	27	28	26	28	29	30	32
Selling, General & Admin	592	478	503	454	415	374	400	356	352	338	303	323	330	302	277	276	266
General & Administrative	132	117	111	96	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Expenses	648	533	556	501	458	414	446	398	384	371	331	351	356	341	367	308	309
Operating Income	103	200	121	70	110	46	79	71	47	38	51	53	57	65	8.27	57	28
Interest Expense	31	37	40	29	35	44	43	21	18	15	6.03	6.11	5.61	5.73	6.68	7.11	7.09
Merger & Restructuring Charges	–	–	–	–	–	–	–	–	4.25	9.74	22	22	17	–	–	–	–
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	–	–	–	0	0	60	0	0
Pretax Income	71	163	81	-71	73	1.60	31	51	29	19	45	47	51	59	-2.31	46	18
Income Tax Expense	24	31	16	9.72	11	-7.91	2.61	9.80	-27	4.71	15	14	15	19	-3.06	15	6.02
Net Income	47	132	64	-81	63	9.52	29	41	55	15	30	32	36	40	0.75	30	12
Net Income to Common	–	–	–	-81	63	9.52	–	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	1.52	4.29	2.10	-2.68	2.14	0.33	1.01	1.45	1.99	0.53	1.10	1.17	1.30	1.43	0.03	1.06	0.42
EPS (Diluted)(per share)	1.51	4.25	2.04	-2.68	1.94	0.32	0.97	1.41	1.97	0.52	1.09	1.16	1.28	1.41	0.03	1.05	0.42
Shares Outstanding (Basic, Weighted)(shares)	31	31	31	30	29	29	28	28	28	28	28	27	28	28	28	29	29
Shares Outstanding (Diluted, Weighted)(shares)	31	31	32	30	32	29	29	29	28	28	28	28	28	29	29	29	29
Dividend per Share(per share)	0.60	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.80	0.65	0.60	0.00	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 55.8%
Operating margin: 8.0%
Net margin: 4.1%
Return on equity, FY2025: 4.7%

Financial strength

Current ratio: 1.48
Debt to equity: 0.80
Debt to assets: 36.3%
Cash to current liabilities: 8.2%

Valuation

P/E ratio: 24.9
Price to sales: 1.01
Price to book: 1.33
Dividend yield: 1.30%